Gelteq (GELS) vs Pulmatrix (PULM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Gelteq is the larger company by market cap ($5.9 million vs $5.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GELS | PULM |
|---|---|---|
| Share price | $0.5488 | $1.53 |
| Market cap | $5.88M | $5.58M |
| 1-day change | -1.98% | +2.49% |
| EPS (TTM) | $-0.44 | $-1.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.01 | $5.24 |
| 52-week low | $0.387 | $1.16 |
| Distance from 52-week high | -72.70% | -70.83% |
| Average volume | 2.86M | 24.09K |
| Shares outstanding | 10.71M | 3.65M |
| Employees | 7 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Gelteq
GELS stock →Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products.
Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees
About Pulmatrix
PULM stock →Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
GELS vs PULM FAQ
Which is bigger, Gelteq or Pulmatrix?
Gelteq (GELS) is larger, with a market capitalization of $5.88M compared with $5.58M for Pulmatrix (PULM).
Are Gelteq and Pulmatrix in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.